Two Sigma Investments, LP Graybug Vision, Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.76 - $1.25 $25,718 - $42,300	-33,840 Reduced 66.28%	17,218 $19,000
Q1 2022 May 16, 2022	SELL	$1.13 - $1.93 $47,813 - $81,664	-42,313 Reduced 45.32%	51,058 $63,000
Q4 2021 Feb 14, 2022	BUY	$1.74 - $3.6 $162,465 - $336,135	93,371 New	93,371 $171,000
Q2 2021 Aug 16, 2021	SELL	$3.53 - $6.1 $264,460 - $456,999	-74,918 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.55 - $35.0 $415,794 - $2.62 Million	74,918 New	74,918 $416,000

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.